Exogenous melatonin reduced blood pressure in late-term ovine fetus via MT1/MT2 receptor pathways

详细信息    查看全文

• 作者：Jianying Tao^a ; ^c ; ¹ ; Juanxiu Lv^a ; ¹ ; Weisheng Li^a ; Pengjie Zhang^a ; Caiping Mao^a ; Zhice Xu^a ; ^b ; ^{xuzhice@suda.edu.cn" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Melatonin ; Fetal blood pressure ; MT1/MT2 receptor ; Luzindole ; Endothelin
• 刊名：Reproductive Biology
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：16
• 期：3
• 页码：212-217
• 全文大小：1063 K

文摘

Melatonin is involved in the regulation of blood pressure through the receptor dependent or independent route. However, the effect of melatonin on fetal blood pressure is unknown. This study investigated the effect of melatonin on blood pressure of the late-term ovine fetus in utero. Melatonin and/or antagonists were intravenously administered into the fetuses. Mean arterial pressure and heart rate were recorded. Fetal blood samples were analyzed for biochemical parameters and hormones, including cortisol, angiotensin I, angiotensin II, aldosterone, atrial natriuretic peptide, corticotrophin-releasing hormone, adrenocorticotropic hormone, and endothelin. Fetal blood pressure was decreased following administration of melatonin, whereas it was increased following administration of luzindole, but not prazosin. Plasma level of endothelin was decreased by melatonin, which was blocked by luzindole. Our study suggested that melatonin reduced fetal blood pressure via MT1/MT2 receptors and possibly involving release of endothelin.